Anti-tumor promoting potential of luteolin against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats
- 1 December 2006
- journal article
- Published by Elsevier BV in Chemico-Biological Interactions
- Vol. 164 (1-2), 1-14
- https://doi.org/10.1016/j.cbi.2006.08.018
Abstract
In this study, we evaluated the anti-tumor potential of luteolin (30 mg/kg, p.o.), combined with cyclophosphamide (10 mg/kg, i.p.) (LU + CYC) orally administered for 20 days; and CYC individually for 10 days against 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary carcinogenesis in Wistar rats. Combination treatment (LU + CYC) inhibited the incidence rate of tumors and decreased tumor volume significantly without changing the total body weight of the animals. Long-term treatment did not show any apparent toxicity in rats. The CYC-treated group showed potential reduction of tumor volume (74%), severe toxicity, and loss of body weight. In order to elucidate the anticancer mechanism of luteolin, antioxidant activities such as superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) generation in the liver, kidney and breast, as well as protein profiles, were also examined. Biochemical analysis of the combination-treated group showed significant (P < 0.01; P < 0.05) inhibition of lipid peroxide (LPx) formation (oxygen-free radicals), the level and the activity of SOD, CAT and GPx were found to be very high than the LU and CYC individually treated rats at a 30 mg/kg dose. 2D gel electrophoresis analysis revealed that (56 kDa) high molecular weight protein was detected in tumors of rats receiving combination treatment than the cancer controls. The biological significance of that protein involved for the dysfunction of cancer cells and induces apoptosis. Histopathological changes also confirmed the formation of tumor tubules and neovascularization after the treatment. Overall, these results suggest that the combination treatment provided antioxidant defense with strong chemopreventive activity against the genesis of DMBA-induced mammary tumors.This publication has 28 references indexed in Scilit:
- Luteolin induced DNA damage leading to human lung squamous carcinoma CH27 cell apoptosisEuropean Journal of Pharmacology, 2005
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- A methylflavan with free radical scavenging properties from Pancratium littoraleFitoterapia, 2001
- An Overview of Chemoprevention: Current Status and Future ProspectsExperimental Biology and Medicine, 1997
- Detoxication Enzymes and ChemopreventionExperimental Biology and Medicine, 1997
- Antineoplastic agents 338. The cancer cell growth inhibitory. Constituents of Terminalia arjuna (Combretaceae)Journal of Ethnopharmacology, 1996
- Nutrition and health aspects of free radicals and antioxidantsFood and Chemical Toxicology, 1994
- [41] Flavonoid antioxidants: Rate constants for reactions with oxygen radicalsMethods in enzymology, 1994
- Free radicals, antioxidant enzymes, and carcinogenesisFree Radical Biology & Medicine, 1990
- Prooxidant States and Tumor PromotionScience, 1985